Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 09, 2021

SELL
$1.68 - $2.45 $2,100 - $3,062
-1,250 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$1.77 - $3.88 $2,212 - $4,850
1,250 New
1,250 $3,000
Q2 2020

Aug 10, 2020

SELL
$1.9 - $2.94 $23,655 - $36,603
-12,450 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$0.56 - $6.1 $6,972 - $75,945
12,450 New
12,450 $32,000

Others Institutions Holding AIM

About AIM ImmunoTech Inc.


  • Ticker AIM
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,049,300
  • Market Cap $10.1M
  • Description
  • AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's products include Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome...
More about AIM
Track This Portfolio

Track Advisory Services Network, LLC Portfolio

Follow Advisory Services Network, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Services Network, LLC with notifications on news.